Reduction of glycaemia in type 2 diabetes – glycemic results

Supported by a grant (U01DK098246) from National Institute of Diabetes and Diseases of the Digestive System and Kidneys (NIDDK) of the National Institutes of Health (PZH); U34 planning scholarship (U34-DK-088043) for process planning with NIDDK; financing of the pre-planning meeting for the U34 application from American Diabetes Association; this National Institute of Heart, Lung and Blood; this Centers for Disease Control and Prevention; resources and facilities from the Department of Veterans Affairs; scholarships (P30 DK017047, P30 DK020541-44, P30 DK020572, P30 DK072476, P30 DK079626, P30 DK092926, U54 GM104940, UL1 TR000170, UL1 TR000439, UL1 TR000445, UL1 TR001102, UL1109 TR00 TR00, UL1345, UL1109 TR00 TR00, UL1345 , UL1 TR002489, UL1 TR002529, UL1 TR002535, UL1 TR002537, UL1 TR002541, and UL1 TR002548 from NIH; educational materials from the National Diabetes Education Program; and donated drugs and materials from Becton Dickinson, Bristol Myers Squibb, Merck, Novo Nordisk, Roche Diagnostics and Sanofi.

Authors’ disclosure forms are available with the full text of this article at

Editorial Committee Members (David M. Nathan, MD, John M. Lachin, Sc.D., Ashok Balasubramanyam, MD, Henry B. Burch, MD, John B. Buse, MD, Nicole M. Butera, Ph. D., Robert M. Cohen, MD, Jill P. Crandall, MD, Steven E. Kahn, MB, Ch.B., Heidi Krause-Steinrauf, MS, Mary E. Larkin, RN, Neda Rasouli, MD, Margaret Tiktin, DNP, Deborah J. Wexler, MD, and Naji Younes, Ph.D.) accept responsibility for the overall content and integrity of this article.

The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

The authors’ data-sharing disclaimer is available with the full text of this article at

We thank the participants whose loyal dedication made this trial possible.

Leave a Comment